Cyteir Therapeutics Inc (CYT) Return on Equity ROE from the third quarter 2023 to third quarter 2022 and annually, average high and low, overall ranking from Sep 30 2023 to Sep 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cyteir Therapeutics Inc   (NASDAQ: CYT)

Cyteir Therapeutics Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Cyteir Therapeutics Inc in the third quarter 2023?
Cyteir Therapeutics Inc recorded a cumulative net loss of $-33 million during 12 months ending in the third quarter 2023, resulting in a negative return on equity (ROE) of -24.88%.

Within the Major Pharmaceutical Preparations industry 115 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 2890, from total ROE ranking in the second quarter 2023 at 2945.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Equity Change -18.83 % -21.98 % -22.65 % -21.89 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -33 -41 -44 -46 -49
Return On Equity (TTM) -24.88 % -28.93 % -29.68 % -28.85 % -28.89 %
CYT's Total Ranking # 2890 # 2945 # 2094 # 3105 # 0
Equity (TTM) in Millions 125 128 135 146 154
Seq. Equity Change -2.16 % -5.33 % -7.73 % -5.03 % -5.95 %
Seq. Net Income Change - - - - -

Back to CYT Management Effectiveness >> CYT's 5 Years Annual ROE >> Compare CYT ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 116
Sector # 309
Overall # 2890

Return On Equity Statistics
High Average Low
17.7 %
-7.12 %
-68.21 %
(Sep 30 2014)   (Sep 30 2022)





CYT Annual Return On Equity (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2014)
2014		 (Dec 31 2013)
2013		 (Dec 31 2012)
2012
Total Equity in Millions 146 187 1,211 1,182 1,804
Y / Y Equity Change -21.89 % -84.53 % 2.46 % -34.5 % 6.56 %
Net Income in Millions -46 -42 154 174 190
Y / Y Net Income Change - - -11.56 % -8.52 % -9.86 %
Return On Equity -31.49 % -22.49 % 12.7 % 14.71 % 10.54 %

Back to CYT Management Effectiveness >> CYT's 5 Years Annual ROE >> Compare CYT ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
CYT's' Return on Equity at Yahoo Finance
CYT's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CYT's Competitors
Subscribers only: Roe for Cyteir Therapeutics Inc 's Suppliers
Subscribers only: Return On Equity for CYT's Customers




Companies with similar Return On Equity at Sep 30 2023, within Healthcare Sector ROE

Date modified: 2026-09-26T07:39:43+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.